Circulating asprosin levels are increased in patients with type 2 diabetes and associated with early-stage diabetic kidney disease.

Zhang, Hongyu; Hu, Wenqi; Zhang, Guang

Zhang, Hongyu; Hu, Wenqi; Zhang, Guang.

Afiliação

Zhang H; Health Management Center, Shandong Provincial Qianfoshan Hospital, The First Affiliated Hospital of Shandong First Medical University, Jinan, 250012, Shandong, China.
Hu W; Health Management Center, Shandong Provincial Qianfoshan Hospital, The First Affiliated Hospital of Shandong First Medical University, Jinan, 250012, Shandong, China.
Zhang G; Health Management Center, Shandong Provincial Qianfoshan Hospital, The First Affiliated Hospital of Shandong First Medical University, Jinan, 250012, Shandong, China. sydyfy89269101@163.com.

Int Urol Nephrol ; 52(8): 1517-1522, 2020 Aug.

Article em En | MEDLINE | ID: mdl-32458209

Assuntos

Diabetes Mellitus Tipo 2/sangue; Nefropatias Diabéticas/sangue; Fibrilina-1/sangue; Estudos Transversais; Feminino; Humanos; Masculino; Pessoa de Meia-Idade

Palavras-chave

Asprosin; Diabetic kidney disease; Type 2 diabetes mellitus

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Nefropatias Diabéticas / Fibrilina-1 Tipo de estudo: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Int Urol Nephrol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google